Louisiana’s 3rd Circuit Court of Appeal has upheld a $257.7 million jury verdict in a lawsuit brought by Attorney General Buddy Caldwell against Janssen Pharmaceutical and Johnson & Johnson for defrauding the state’s Medicaid program, the attorney general’s office announced.
Caldwell sued Johnson & Johnson for serious misrepresentations regarding the drug Risperdal’s link to diabetes in order to obtain funds from Louisiana’s Medicaid program.
In 2010, in St. Landry Parish ordered Johnson & Johnson to pay $257.7 million to Louisiana.
“The appeals court ruling serves as a powerful reminder that a drug company’s misleading safety claims will not be tolerated in Louisiana,” said Attorney General Caldwell. “The Attorney General’s Office will continue to move aggressively against those who commit Medicaid fraud.”
After a multi-day trial, the jury unanimously concluded that the pharmaceutical companies had violated the Louisiana Medical Assistance Programs Integrity Law (MAPIL) with an aggressive marketing campaign, the appeals court noted in the written opinion.
The appeals court said it found that the “jury was not manifestly erroneous in determining that the pharmaceutical company had violated” the law, and affirmed the lower court decision.
Topics Louisiana
Was this article valuable?
Here are more articles you may enjoy.
Dunkin’ Cashier in Georgia, Stabbed by Rapper, Can’t Claim More Than Workers’ Comp 
One of Highest Property Claims Severity Recorded in Q3 on Low Volume, Says Verisk 
Brookfield Targets Global Dominance in P/C Insurance Coverage 
Baldwin Group to Buy CAC Group for About $1B in Cash and Stock 
